Lack of uniformity in cardiac assessment during trastuzumab therapy.

Lack of uniformity in cardiac assessment during trastuzumab therapy.

Item
http://www.wikidata.org/entity/Q39746124
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer.Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.Early cardiac function monitoring for detection of subclinical Doxorubicin cardiotoxicity in young adult patients with breast cancer.Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab.Cardiotoxicity due to chemotherapy: role of cardiac imaging.EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.Cardiac monitoring during adjuvant trastuzumab therapy: Guideline adherence in clinical practice.
P2860

Lack of uniformity in cardiac assessment during trastuzumab therapy.

Item
http://www.wikidata.org/entity/Q39746124
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Lack of uniformity in cardiac assessment during trastuzumab therapy.
@en
Lack of uniformity in cardiac assessment during trastuzumab therapy.
@nl
type
label
Lack of uniformity in cardiac assessment during trastuzumab therapy.
@en
Lack of uniformity in cardiac assessment during trastuzumab therapy.
@nl
prefLabel
Lack of uniformity in cardiac assessment during trastuzumab therapy.
@en
Lack of uniformity in cardiac assessment during trastuzumab therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Lack of uniformity in cardiac assessment during trastuzumab therapy.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1524-4741.2011.01101.X
P433
P478
P577
P698